Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Quality-of-life outcomes after total neoadjuvant short course radiotherapy, chemo-immunotherapy, and total mesorectal excision for locally advanced rectal cancer.
Authors
Ali Shamseddine
American University of Beirut Medical Center, Beirut, Lebanon;
Ali Shamseddine , Laudy Chehade , Joseph Gergi Kattan , Sally Naji Temraz , Rula Amarin , Tala Awabdeh , Maya Charafeddine , Monita Al Darazi , Rim Turfa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Clinical Trial Registration Number
NCT03503630
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 63)
DOI
10.1200/JCO.2023.41.4_suppl.63
Abstract #
63
Poster Bd #
C18
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
High immunoscore as a predictor of outcome in patients who underwent chemoimmuno-therapy in locally advanced rectal cancer: A post-hoc analysis of the correlation between immunoscore and pCR in the Averectal study.
First Author: Ali Shamseddine
Poster
2024 ASCO Annual Meeting
Total neoadjuvant therapy with split-course hypofraction radiotherapy combined with CAPOX and envafolimab followed by local excision for locally advanced very low rectal cancer (TRACE-LE): An open-label, single-arm, multicenter, phase II trial.
First Author: Weizhong Jiang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
No operation after short course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer: The prospective, single arm NOAHS-ARC trial.
First Author: Felipe Fernando Quezada
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TnT) with FOLFOX followed by short course radiation in locally advanced rectal cancer: A phase II study.
First Author: Janice Zhao